Novartis AG (ADR) (NVS) Reaches $81.68 After 6.00% Up Move; Team Health Holdings (TMH) Has 0.99 Sentiment

May 31, 2017 - By Hazel Jackson

Team Health Holdings, Inc. is a United States physician services company. The company has market cap of $. The Firm supplies outsourced healthcare professional staffing and administrative services to hospitals and other healthcare providers in the United States. It currently has negative earnings. It operates through four divisions: Hospital Based Services, IPC Healthcare, Specialty Services and Other Services.

The stock of Novartis AG (ADR) (NYSE:NVS) is a huge mover today! About 295,097 shares traded. Novartis AG (ADR) (NYSE:NVS) has risen 7.67% since May 31, 2016 and is uptrending. It has underperformed by 9.03% the S&P500.The move comes after 6 months positive chart setup for the $213.16B company. It was reported on May, 31 by Barchart.com. We have $86.58 PT which if reached, will make NYSE:NVS worth $12.79 billion more.

Novartis AG is a holding company, which provides healthcare solutions. The company has market cap of $213.16 billion. The Firm is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. It has a 30.75 P/E ratio. The Company’s divisions include Innovative Medicines, Sandoz, Alcon and Corporate activities.

Among 13 analysts covering Novartis Ag (NYSE:NVS), 4 have Buy rating, 2 Sell and 7 Hold. Therefore 31% are positive. Novartis Ag had 21 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Novartis AG (ADR) (NYSE:NVS) has “Neutral” rating given on Friday, March 24 by JP Morgan. Credit Suisse downgraded the shares of NVS in report on Wednesday, January 11 to “Neutral” rating. The stock has “Market Perform” rating by Cowen & Co on Wednesday, April 5. Leerink Swann downgraded it to “Market Perform” rating and $85 target in Wednesday, March 23 report. The rating was downgraded by JP Morgan on Tuesday, January 3 to “Neutral”. The stock of Novartis AG (ADR) (NYSE:NVS) earned “Neutral” rating by Goldman Sachs on Thursday, March 23. The firm earned “Buy” rating on Monday, October 10 by Chardan Capital Markets. The firm has “Neutral” rating given on Tuesday, March 29 by Citigroup. On Wednesday, April 19 the stock rating was maintained by JP Morgan with “Neutral”. On Wednesday, March 8 the stock rating was upgraded by Societe Generale to “Buy”.

Analysts await Novartis AG (ADR) (NYSE:NVS) to report earnings on July, 18. They expect $1.18 earnings per share, down 3.28% or $0.04 from last year’s $1.22 per share. NVS’s profit will be $3.08B for 17.31 P/E if the $1.18 EPS becomes a reality. After $1.13 actual earnings per share reported by Novartis AG (ADR) for the previous quarter, Wall Street now forecasts 4.42% EPS growth.

It is down 0.00% since May 31, 2016 and is . It has underperformed by 16.70% the S&P500.

S. Muoio & Co. Llc holds 6.58% of its portfolio in TeamHealth Holdings Inc for 290,000 shares. Omni Partners Llp owns 600,985 shares or 5.84% of their US portfolio. Moreover, Davide Leone & Partners Investment Co Llp has 4.98% invested in the company for 956,867 shares. The New York-based Jana Partners Llc has invested 4.49% in the stock. Halcyon Management Partners Lp, a New York-based fund reported 415,658 shares.